Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Zafgen Inc. (ZFGN)

0.99   -0.17 (-14.66%) 05-28 16:00
Open: 1.02 Pre. Close: 1.16
High: 1.24 Low: 0.95
Volume: 4,239,174 Market Cap: 3M
Zafgen Inc is a biopharmaceutical company engaged in improving the health and well-being of patients affected by obesity and complex metabolic disorders. Its product candidate include Beloranib.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.241 - 1.247 1.247 - 1.252
Low: 0.938 - 0.944 0.944 - 0.948
Close: 0.981 - 0.991 0.991 - 0.997

Technical analysis

as of: 2020-06-19 4:35:45 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.25     One year: 1.51
Support: Support1: 0.72    Support2: 0.60
Resistance: Resistance1: 1.07    Resistance2: 1.29
Pivot: 0.92
Moving Average: MA(5): 1.05     MA(20): 0.90
MA(100): 0.99     MA(250): 0.95
MACD: MACD(12,26): 0.06     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 62.66     %D(3): 72.57
RSI: RSI(14): 56.93
52-week: High: 1.88  Low: 0.62  Change(%): -45.9
Average Vol(K): 3-Month: 40699  10-Days: 163585

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ZFGN has closed below upper band by 34.6%. Bollinger Bands are 51% wider than normal. The large width of the bands suggest high volatility as compared to ZFGN's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Mon, 15 Jun 2020
Hedge Funds Warming Up To Vertex Energy Inc (VTNR) - Yahoo Finance

Thu, 11 Jun 2020
Zafgen Inc. (NASDAQ:ZFGN) Announces Reverse Merger With Chondrial Therapeutics With New Company Operating As Larimar Therapeutics - BP Journal

Fri, 29 May 2020
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics - GlobeNewswire

Tue, 26 May 2020
Is Zafgen Inc (ZFGN) Stock About to Get Hot Tuesday? - InvestorsObserver

Fri, 22 May 2020
Should Zafgen Inc (ZFGN) Stock be in Your Portfolio? - InvestorsObserver

Wed, 06 May 2020
Do Traders View Zafgen Inc (ZFGN) Stock's Current Trend Positively? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS Est This Year -2.230
EPS Est Next Year -1.840
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.803
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.